Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China Natural Killer Cells Therapeutics market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Natural Killer Cells Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Natural Killer Cells Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
NKT Therapeutics
Celgene Corporation
Ziopharm Oncology
Nantkwest
Affimed
Fate Therapeutics
Glycostem Therapeutics
Nkarta Therapeutics
Innate Pharma
Fortress Biotech
By Type:
NK Cell Therapies
NK Cell Directed Antibodies
By End-User:
Research Centers & Institutes
Hospitals
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Natural Killer Cells Therapeutics Market
-
1.3 Market Segment by Type
-
1.3.1 China Natural Killer Cells Therapeutics Market Size and Growth Rate of NK Cell Therapies from 2016 to 2027
-
1.3.2 China Natural Killer Cells Therapeutics Market Size and Growth Rate of NK Cell Directed Antibodies from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Natural Killer Cells Therapeutics Market Size and Growth Rate of Research Centers & Institutes from 2016 to 2027
-
1.4.2 China Natural Killer Cells Therapeutics Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.3 China Natural Killer Cells Therapeutics Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Natural Killer Cells Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Natural Killer Cells Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Natural Killer Cells Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Natural Killer Cells Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Natural Killer Cells Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Natural Killer Cells Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Natural Killer Cells Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Natural Killer Cells Therapeutics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Natural Killer Cells Therapeutics by Major Types
-
3.4.1 Market Size and Growth Rate of NK Cell Therapies
-
3.4.2 Market Size and Growth Rate of NK Cell Directed Antibodies
4 Segmentation of Natural Killer Cells Therapeutics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Natural Killer Cells Therapeutics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Natural Killer Cells Therapeutics in Research Centers & Institutes
-
4.4.2 Market Size and Growth Rate of Natural Killer Cells Therapeutics in Hospitals
-
4.4.3 Market Size and Growth Rate of Natural Killer Cells Therapeutics in Others
5 Market Analysis by Regions
-
5.1 China Natural Killer Cells Therapeutics Production Analysis by Regions
-
5.2 China Natural Killer Cells Therapeutics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Natural Killer Cells Therapeutics Landscape Analysis
-
6.1 North China Natural Killer Cells Therapeutics Landscape Analysis by Major Types
-
6.2 North China Natural Killer Cells Therapeutics Landscape Analysis by Major End-Users
7 Central China Natural Killer Cells Therapeutics Landscape Analysis
-
7.1 Central China Natural Killer Cells Therapeutics Landscape Analysis by Major Types
-
7.2 Central China Natural Killer Cells Therapeutics Landscape Analysis by Major End-Users
8 South China Natural Killer Cells Therapeutics Landscape Analysis
-
8.1 South China Natural Killer Cells Therapeutics Landscape Analysis by Major Types
-
8.2 South China Natural Killer Cells Therapeutics Landscape Analysis by Major End-Users
9 East China Natural Killer Cells Therapeutics Landscape Analysis
-
9.1 East China Natural Killer Cells Therapeutics Landscape Analysis by Major Types
-
9.2 East China Natural Killer Cells Therapeutics Landscape Analysis by Major End-Users
10 Northeast China Natural Killer Cells Therapeutics Landscape Analysis
-
10.1 Northeast China Natural Killer Cells Therapeutics Landscape Analysis by Major Types
-
10.2 Northeast China Natural Killer Cells Therapeutics Landscape Analysis by Major End-Users
11 Southwest China Natural Killer Cells Therapeutics Landscape Analysis
-
11.1 Southwest China Natural Killer Cells Therapeutics Landscape Analysis by Major Types
-
11.2 Southwest China Natural Killer Cells Therapeutics Landscape Analysis by Major End-Users
12 Northwest China Natural Killer Cells Therapeutics Landscape Analysis
-
12.1 Northwest China Natural Killer Cells Therapeutics Landscape Analysis by Major Types
-
12.2 Northwest China Natural Killer Cells Therapeutics Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 NKT Therapeutics
-
13.1.1 NKT Therapeutics Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Celgene Corporation
-
13.2.1 Celgene Corporation Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Ziopharm Oncology
-
13.3.1 Ziopharm Oncology Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Nantkwest
-
13.4.1 Nantkwest Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Affimed
-
13.5.1 Affimed Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Fate Therapeutics
-
13.6.1 Fate Therapeutics Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Glycostem Therapeutics
-
13.7.1 Glycostem Therapeutics Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Nkarta Therapeutics
-
13.8.1 Nkarta Therapeutics Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Innate Pharma
-
13.9.1 Innate Pharma Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Fortress Biotech
-
13.10.1 Fortress Biotech Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Natural Killer Cells Therapeutics Market Size and Growth Rate of NK Cell Therapies from 2016 to 2027
-
Figure China Natural Killer Cells Therapeutics Market Size and Growth Rate of NK Cell Directed Antibodies from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Natural Killer Cells Therapeutics Market Size and Growth Rate of Research Centers & Institutes from 2016 to 2027
-
Figure China Natural Killer Cells Therapeutics Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure China Natural Killer Cells Therapeutics Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Natural Killer Cells Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Natural Killer Cells Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Natural Killer Cells Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Natural Killer Cells Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Natural Killer Cells Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Natural Killer Cells Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Natural Killer Cells Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Natural Killer Cells Therapeutics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Natural Killer Cells Therapeutics
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Natural Killer Cells Therapeutics by Different Types from 2016 to 2027
-
Table Consumption Share of Natural Killer Cells Therapeutics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of NK Cell Therapies
-
Figure Market Size and Growth Rate of NK Cell Directed Antibodies
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Natural Killer Cells Therapeutics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Natural Killer Cells Therapeutics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Research Centers & Institutes
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Others
-
Table China Natural Killer Cells Therapeutics Production by Regions
-
Table China Natural Killer Cells Therapeutics Production Share by Regions
-
Figure China Natural Killer Cells Therapeutics Production Share by Regions in 2016
-
Figure China Natural Killer Cells Therapeutics Production Share by Regions in 2021
-
Figure China Natural Killer Cells Therapeutics Production Share by Regions in 2027
-
Table China Natural Killer Cells Therapeutics Consumption by Regions
-
Table China Natural Killer Cells Therapeutics Consumption Share by Regions
-
Figure China Natural Killer Cells Therapeutics Consumption Share by Regions in 2016
-
Figure China Natural Killer Cells Therapeutics Consumption Share by Regions in 2021
-
Figure China Natural Killer Cells Therapeutics Consumption Share by Regions in 2027
-
Table North China Natural Killer Cells Therapeutics Consumption by Types from 2016 to 2027
-
Table North China Natural Killer Cells Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure North China Natural Killer Cells Therapeutics Consumption Share by Types in 2016
-
Figure North China Natural Killer Cells Therapeutics Consumption Share by Types in 2021
-
Figure North China Natural Killer Cells Therapeutics Consumption Share by Types in 2027
-
Table North China Natural Killer Cells Therapeutics Consumption by End-Users from 2016 to 2027
-
Table North China Natural Killer Cells Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure North China Natural Killer Cells Therapeutics Consumption Share by End-Users in 2016
-
Figure North China Natural Killer Cells Therapeutics Consumption Share by End-Users in 2021
-
Figure North China Natural Killer Cells Therapeutics Consumption Share by End-Users in 2027
-
Table Central China Natural Killer Cells Therapeutics Consumption by Types from 2016 to 2027
-
Table Central China Natural Killer Cells Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Central China Natural Killer Cells Therapeutics Consumption Share by Types in 2016
-
Figure Central China Natural Killer Cells Therapeutics Consumption Share by Types in 2021
-
Figure Central China Natural Killer Cells Therapeutics Consumption Share by Types in 2027
-
Table Central China Natural Killer Cells Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Central China Natural Killer Cells Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Natural Killer Cells Therapeutics Consumption Share by End-Users in 2016
-
Figure Central China Natural Killer Cells Therapeutics Consumption Share by End-Users in 2021
-
Figure Central China Natural Killer Cells Therapeutics Consumption Share by End-Users in 2027
-
Table South China Natural Killer Cells Therapeutics Consumption by Types from 2016 to 2027
-
Table South China Natural Killer Cells Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure South China Natural Killer Cells Therapeutics Consumption Share by Types in 2016
-
Figure South China Natural Killer Cells Therapeutics Consumption Share by Types in 2021
-
Figure South China Natural Killer Cells Therapeutics Consumption Share by Types in 2027
-
Table South China Natural Killer Cells Therapeutics Consumption by End-Users from 2016 to 2027
-
Table South China Natural Killer Cells Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure South China Natural Killer Cells Therapeutics Consumption Share by End-Users in 2016
-
Figure South China Natural Killer Cells Therapeutics Consumption Share by End-Users in 2021
-
Figure South China Natural Killer Cells Therapeutics Consumption Share by End-Users in 2027
-
Table East China Natural Killer Cells Therapeutics Consumption by Types from 2016 to 2027
-
Table East China Natural Killer Cells Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure East China Natural Killer Cells Therapeutics Consumption Share by Types in 2016
-
Figure East China Natural Killer Cells Therapeutics Consumption Share by Types in 2021
-
Figure East China Natural Killer Cells Therapeutics Consumption Share by Types in 2027
-
Table East China Natural Killer Cells Therapeutics Consumption by End-Users from 2016 to 2027
-
Table East China Natural Killer Cells Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure East China Natural Killer Cells Therapeutics Consumption Share by End-Users in 2016
-
Figure East China Natural Killer Cells Therapeutics Consumption Share by End-Users in 2021
-
Figure East China Natural Killer Cells Therapeutics Consumption Share by End-Users in 2027
-
Table Northeast China Natural Killer Cells Therapeutics Consumption by Types from 2016 to 2027
-
Table Northeast China Natural Killer Cells Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Natural Killer Cells Therapeutics Consumption Share by Types in 2016
-
Figure Northeast China Natural Killer Cells Therapeutics Consumption Share by Types in 2021
-
Figure Northeast China Natural Killer Cells Therapeutics Consumption Share by Types in 2027
-
Table Northeast China Natural Killer Cells Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northeast China Natural Killer Cells Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Natural Killer Cells Therapeutics Consumption Share by End-Users in 2016
-
Figure Northeast China Natural Killer Cells Therapeutics Consumption Share by End-Users in 2021
-
Figure Northeast China Natural Killer Cells Therapeutics Consumption Share by End-Users in 2027
-
Table Southwest China Natural Killer Cells Therapeutics Consumption by Types from 2016 to 2027
-
Table Southwest China Natural Killer Cells Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Natural Killer Cells Therapeutics Consumption Share by Types in 2016
-
Figure Southwest China Natural Killer Cells Therapeutics Consumption Share by Types in 2021
-
Figure Southwest China Natural Killer Cells Therapeutics Consumption Share by Types in 2027
-
Table Southwest China Natural Killer Cells Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Southwest China Natural Killer Cells Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Natural Killer Cells Therapeutics Consumption Share by End-Users in 2016
-
Figure Southwest China Natural Killer Cells Therapeutics Consumption Share by End-Users in 2021
-
Figure Southwest China Natural Killer Cells Therapeutics Consumption Share by End-Users in 2027
-
Table Northwest China Natural Killer Cells Therapeutics Consumption by Types from 2016 to 2027
-
Table Northwest China Natural Killer Cells Therapeutics Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Natural Killer Cells Therapeutics Consumption Share by Types in 2016
-
Figure Northwest China Natural Killer Cells Therapeutics Consumption Share by Types in 2021
-
Figure Northwest China Natural Killer Cells Therapeutics Consumption Share by Types in 2027
-
Table Northwest China Natural Killer Cells Therapeutics Consumption by End-Users from 2016 to 2027
-
Table Northwest China Natural Killer Cells Therapeutics Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Natural Killer Cells Therapeutics Consumption Share by End-Users in 2016
-
Figure Northwest China Natural Killer Cells Therapeutics Consumption Share by End-Users in 2021
-
Figure Northwest China Natural Killer Cells Therapeutics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of NKT Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of NKT Therapeutics
-
Figure Sales and Growth Rate Analysis of NKT Therapeutics
-
Figure Revenue and Market Share Analysis of NKT Therapeutics
-
Table Product and Service Introduction of NKT Therapeutics
-
Table Company Profile and Development Status of Celgene Corporation
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene Corporation
-
Figure Sales and Growth Rate Analysis of Celgene Corporation
-
Figure Revenue and Market Share Analysis of Celgene Corporation
-
Table Product and Service Introduction of Celgene Corporation
-
Table Company Profile and Development Status of Ziopharm Oncology
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ziopharm Oncology
-
Figure Sales and Growth Rate Analysis of Ziopharm Oncology
-
Figure Revenue and Market Share Analysis of Ziopharm Oncology
-
Table Product and Service Introduction of Ziopharm Oncology
-
Table Company Profile and Development Status of Nantkwest
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nantkwest
-
Figure Sales and Growth Rate Analysis of Nantkwest
-
Figure Revenue and Market Share Analysis of Nantkwest
-
Table Product and Service Introduction of Nantkwest
-
Table Company Profile and Development Status of Affimed
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Affimed
-
Figure Sales and Growth Rate Analysis of Affimed
-
Figure Revenue and Market Share Analysis of Affimed
-
Table Product and Service Introduction of Affimed
-
Table Company Profile and Development Status of Fate Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fate Therapeutics
-
Figure Sales and Growth Rate Analysis of Fate Therapeutics
-
Figure Revenue and Market Share Analysis of Fate Therapeutics
-
Table Product and Service Introduction of Fate Therapeutics
-
Table Company Profile and Development Status of Glycostem Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Glycostem Therapeutics
-
Figure Sales and Growth Rate Analysis of Glycostem Therapeutics
-
Figure Revenue and Market Share Analysis of Glycostem Therapeutics
-
Table Product and Service Introduction of Glycostem Therapeutics
-
Table Company Profile and Development Status of Nkarta Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nkarta Therapeutics
-
Figure Sales and Growth Rate Analysis of Nkarta Therapeutics
-
Figure Revenue and Market Share Analysis of Nkarta Therapeutics
-
Table Product and Service Introduction of Nkarta Therapeutics
-
Table Company Profile and Development Status of Innate Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Innate Pharma
-
Figure Sales and Growth Rate Analysis of Innate Pharma
-
Figure Revenue and Market Share Analysis of Innate Pharma
-
Table Product and Service Introduction of Innate Pharma
-
Table Company Profile and Development Status of Fortress Biotech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fortress Biotech
-
Figure Sales and Growth Rate Analysis of Fortress Biotech
-
Figure Revenue and Market Share Analysis of Fortress Biotech
-
Table Product and Service Introduction of Fortress Biotech
-
